This protocol defines the next clinical step for patients with overactive bladder (OAB) who have already received minimally invasive treatment but have not achieved adequate control of their symptoms.
The prior line of management included minimally invasive procedures: sacral neuromodulation, percutaneous tibial nerve stimulation, or intradetrusor botulinum toxin injection. That treatment line did not achieve the required goals — specifically, a meaningful reduction in urgency urinary incontinence episodes and urinary frequency. Non-achievement of those targets triggers escalation to this next-line protocol.
DOI: 10.1097/JU.0000000000003985
The clinician may offer bladder augmentation cystoplasty or urinary diversion in severely impacted patients with OAB who have not responded to all other therapeutic options.
View source ↗